Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NAMS compared with MIRM: revenue, margins and what each company keeps, and the suppliers and customers both name
NAMS
NewAmsterdam Pharma Co N.V.
Change
Mkt cap
Revenue
Revenue
MIRM
Mirum Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NAMS
NewAmsterdam Pharma Co N.V.
vs
MIRM
Mirum Pharmaceuticals, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
NAMS: latest quarter is a loss; flow not drawable. MIRM: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NAMS, solid
MIRM, dashed
NAMS
NewAmsterdam Pharma Co N.V.
Change
20.05
▼
−3.42%
· post 20.05
Mkt cap
$2.4B
Revenue
$4M
Q2 FY26
Revenue
$23M
FY25
MIRM
Mirum Pharmaceuticals, Inc.
Change
84.76
▼
−1.89%
· post 84.74
Closed
Oct 30 '26
Mkt cap
$5.5B
Revenue
$176M
Q2 FY26
Revenue
$521M
FY25
vs
Compare
Closed
Oct 30 '26
NAMS
NewAmsterdam Pharma Co N.V.
vs
MIRM
Mirum Pharmaceuticals, Inc.
20.05
▼
−3.42%
post 20.05
Price
84.76
▼
−1.89%
post 84.74
$2.4B
Mkt cap
$5.5B
Q2 FY26
$4M
Revenue
$176M
Q2 FY26
FY25
$23M
Revenue
$521M
FY25
Change
Change
NAMS
20.05
▼
−3.42%
vs
MIRM
84.76
▼
−1.89%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only NAMS
0
None
Shared
0
No disclosed counterparties: NAMS.
Only MIRM
14
PFE
Pfizer
supplier
SNYNF
Sanofi-Aventis Deutschland GmbH
supplier
—
Bluejay Therapeutics
unlisted
supplier
—
Dart Neuroscience
unlisted
supplier
10 more · MIRM chain
›
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR